BA
SPPI

Bard Associates’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bard Associates’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-129,380
Closed -$964K – 183
2017
Q2 		$964K Sell
129,380
-325
-0.3% -$2.12K 0.44% 84
2017
Q1 		$843K Sell
129,705
-4,725
-4% -$26.4K 0.39% 94
2016
Q4 		$596K Sell
134,430
-10,650
-7% -$44.7K 0.28% 102
2016
Q3 		$678K Sell
145,080
-6,650
-4% -$39.4K 0.33% 97
2016
Q2 		$997K Sell
151,730
-3,875
-2% -$27.4K 0.53% 71
2016
Q1 		$990K Sell
155,605
-6,105
-4% -$31.3K 0.57% 73
2015
Q4 		$975K Sell
161,710
-22,500
-12% -$129K 0.58% 65
2015
Q3 		$1.1M Sell
184,210
-4,950
-3% -$34.4K 0.63% 62
2015
Q2 		$1.29M Sell
189,160
-18,800
-9% -$119K 0.64% 62
2015
Q1 		$1.26M Sell
207,960
-17,040
-8% -$113K 0.61% 67
2014
Q4 		$1.56M Sell
225,000
-24,160
-10% -$178K 0.73% 56
2014
Q3 		$2.03M Sell
249,160
-975
-0.4% -$7.63K 0.95% 37
2014
Q2 		$2.03M Sell
250,135
-3,600
-1% -$27.3K 0.8% 38
2014
Q1 		$1.99M Sell
253,735
-310
-0.1% -$2.62K 0.84% 36
2013
Q4 		$2.25M Sell
254,045
-3,250
-1% -$29K 0.93% 31
2013
Q3 		$2.16M Buy
257,295
+200
+0.1% +$1.62K 0.95% 30
2013
Q2 		$1.92M Buy
+257,095
New +$1.97M 0.9% 36

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bard Associates's SPPI Position: Q3 2017 in Review

Bard Associates sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2017, closing a stake of 129,380 shares — an estimated $964K sold.

Bard Associates first reported a position in SPPI in Q2 2013 and held it in 17 quarters. The position peaked at $2.25M in Q4 2013. 158 funds tracked by Wall St. Rank hold SPPI as of Q3 2017.

  • Bard Associates reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2017 after selling out during the quarter.
  • Bard Associates sold 129,380 Spectrum Pharmaceuticals Inc shares in Q3 2017, an estimated $964K.
  • Bard Associates first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 17 quarters.
  • Bard Associates's Spectrum Pharmaceuticals Inc position peaked at $2.25M in Q4 2013.
  • 158 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2017.

Based on Bard Associates's 13F filing for Q3 2017, filed 14 Nov 2017.